Stockley’s Drug Interactions is the most indispensable source of drug interaction information available.
It provides expertly authored advice on managing drug interactions, and will quickly and reliably help you decide your best course of action.
SubscribeContent Updates
With over 4,500 detailed records, access drug-drug, drug-herb, drug-food interactions and much more
Featuring a concise summary at the start of each record, you can also discover the clinical evidence, mechanism, importance and management of each interaction
Contains detailed, fully referenced and international information with an unrivalled depth of content
*based on average data in the last 12 months
Stockley’s Drug Interactions update with new and revised monographs.
For this update, several sections have been completely re-validated and updated, including those on activated factor XA inhibitors, cranberry, dabigatran, ivacaftor and related drugs, statins, tetracyclines, and urinary antimuscarinics. In addition, 15 new tyrosine kinase inhibitors have been added. This update contains 92 new monographs, and 213 existing monographs have been updated.
Stockley’s Drug Interactions update with new and revised monographs.
This update includes the addition of letermovir, and the monographs for sugammadex have been fully revised and updated. There are 12 new monographs and 10 revised monographs in this update.
Stockley’s Drug Interactions update with new and revised monographs.
This update contains 1 new monograph and 15 revised monographs. In light of reviews by the FDA in the US about the effects of concurrent use of benzodiazepines and opioids, the relevant monographs have been partially revised and updated. The monograph on histamine has been fully revised and updated.
Stockley’s Drug Interactions update with new and revised monographs.
This update contains 3 new monographs and 12 revised monographs. The monographs on tetrabenazine have been fully revised and updated, and the related drugs, deutetrabenazine and valbenazine have been added.
Stockley’s Drug Interactions update with new and revised monographs.
This update contains 13 new monographs and 24 revised monographs. The monographs on the growth hormone release stimulants have been revised, with the addition of macimorelin, somatorelin, and tesamorelin. The sections on sevelamer and sodium oxybate have been re-validated and updated, and verteporfin has been added.
Stockley’s Drug Interactions update with new and revised monographs.
For this update, the monographs on the anti-androgens have been completely re-validated and updated, and apalutamide has been added. There are 7 new monographs and 31 existing monographs have been updated.
